Case Report: New-onset type B aortic dissection after chemoimmunotherapy and lung resection for small-cell lung cancer

Background Aortic dissection can emerge during multimodal cancer treatment without typical symptoms or preceding aortic dilatation. We report a new-onset type B dissection detected during postoperative reassessment after chemoimmunotherapy and lung resection for small-cell lung cancer. Case description A 56-year-old woman with cT4N1M0 small-cell lung cancer and radiologically assessed left pulmonary artery involvement received two cycles of adebrelimab, etoposide, and cisplatin, followed by video-assisted thoracoscopic left upper lobectomy. The outside pathology report described a major pathological response, negative margins, and no tumor in 24 examined lymph nodes. Contrast-enhanced computed tomography (CT) 28 days after surgery revealed a Stanford type B aortic dissection with focal adventitial discontinuity, without documented chest or back pain. Neither pretreatment nor preoperative imaging showed a definite dissection. Concern for rupture prompted thoracic endovascular aortic repair. The intimal entry tear was excluded, and the patient was discharged three days later. Adebrelimab was administered on September 13, 2026, followed by etoposide and cisplatin beginning on September 14. Follow-up contrast-enhanced CT of the thoracic, abdominal, and pelvic vessels was obtained on October 10, 2026. Conclusion This case documents new-onset type B aortic dissection during multimodal treatment for small-cell lung cancer, despite a marked tumor response and no typical aortic symptoms. The focal adventitial discontinuity near the reported operative field makes local perioperative injury a leading consideration. Direct comparison of the aorta on serial oncologic computed tomography should form part of postoperative reassessment; new structural abnormalities warrant prompt vascular evaluation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-19
DOI
https://doi.org/10.3389/fonc.2026.2024707
Primary Topic
Aortic Disease and Treatment Approaches
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: New-onset type B aortic dissection after chemoimmunotherapy and lung resection for small-cell lung cancer

Jiangjiang Liu, Haitao Ma, Langlang Deng, Fei Lu et al.
Frontiers in Oncology
Aortic Disease and Treatment Approaches
article

Case Report: New-onset type B aortic dissection after chemoimmunotherapy and lung resection for small-cell lung cancer

Jiangjiang Liu, Haitao Ma, Langlang Deng, Fei Lu, Wei Feng, Yu Zhang
article en

Abstract

Background Aortic dissection can emerge during multimodal cancer treatment without typical symptoms or preceding aortic dilatation. We report a new-onset type B dissection detected during postoperative reassessment after chemoimmunotherapy and lung resection for small-cell lung cancer. Case description A 56-year-old woman with cT4N1M0 small-cell lung cancer and radiologically assessed left pulmonary artery involvement received two cycles of adebrelimab, etoposide, and cisplatin, followed by video-assisted thoracoscopic left upper lobectomy. The outside pathology report described a major pathological response, negative margins, and no tumor in 24 examined lymph nodes. Contrast-enhanced computed tomography (CT) 28 days after surgery revealed a Stanford type B aortic dissection with focal adventitial discontinuity, without documented chest or back pain. Neither pretreatment nor preoperative imaging showed a definite dissection. Concern for rupture prompted thoracic endovascular aortic repair. The intimal entry tear was excluded, and the patient was discharged three days later. Adebrelimab was administered on September 13, 2026, followed by etoposide and cisplatin beginning on September 14. Follow-up contrast-enhanced CT of the thoracic, abdominal, and pelvic vessels was obtained on October 10, 2026. Conclusion This case documents new-onset type B aortic dissection during multimodal treatment for small-cell lung cancer, despite a marked tumor response and no typical aortic symptoms. The focal adventitial discontinuity near the reported operative field makes local perioperative injury a leading consideration. Direct comparison of the aorta on serial oncologic computed tomography should form part of postoperative reassessment; new structural abnormalities warrant prompt vascular evaluation.

Frontiers in OncologyVol. 16
The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital) (CN)
Aortic Disease and Treatment Approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon